South Korea Makes Biotech IPOs More Transparent for Investors

South Korea just overhauled disclosure rules for pharmaceutical and biotech companies to protect everyday investors from misleading claims.

The changes come after Samchundang Pharm's stock crashed 89% following an unverified contract announcement.